Reuters logo
Ultragenyx seizure drug fails mid-stage study
2017年3月22日 / 晚上9点28分 / 8 个月前

Ultragenyx seizure drug fails mid-stage study

March 22 (Reuters) - Ultragenyx Pharmaceutical Inc said on Wednesday its drug to treat patients with seizures did not meet the main goal in a mid-stage study.

The company said the study did not show statistical significance in reducing the frequency of seizures among patients treated with the drug compared to a placebo. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below